Trial Profile
Quality Assurance Project in Patients With Advanced Prostate Carcinoma - Evaluation of Tolerability, Quality of Life and Usage of Zoladex [goserelin] 10,8 SafeSystem
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 30 Oct 2007
Price :
$35
*
At a glance
- Drugs Goserelin (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- Sponsors AstraZeneca
- 30 Oct 2007 New trial record.